Risk Factor for Cholestasis in Neonates Receiving TPN(Total Parenteral Nutrition) (NCT05163145) | Clinical Trial Compass
UnknownNot Applicable
Risk Factor for Cholestasis in Neonates Receiving TPN(Total Parenteral Nutrition)
50 participantsStarted 2022-07-01
Plain-language summary
The aim of this study is to evaluate the risk factors of PNAC in neonates
Who can participate
Age range1 Day – 28 Days
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Neonates who received PN for ≥14 days
Exclusion Criteria::Neonates with major congenital anomaly, cholestasis at birth,diseases associated with cholestasis (i.e.,inborn errors of metabolism,viral hepatitis,cystic fibrosis and any primary cholestatic liver diseases)that were diagnosed while hospitalized.the possibility of surgical causes of conjugated hyperbilirubinemia(such as biliary atresia,choledochalcyst on abdominal ultrasonography,and hepatobiliary scintigraphy
\-